These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22635083)

  • 1. Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma.
    Fischbach J; Gut P; Matysiak-Grześ M; Klimowicz A; Gryczyńska M; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):273-8. PubMed ID: 22635083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant insulinoma in childhood.
    Karachaliou F; Vlachopapadopoulou E; Kaldrymidis P; Simatos G; Zacharea M; Spanidou-Karvouni E; Michalacos S; Voros D
    J Pediatr Endocrinol Metab; 2006 May; 19(5):757-60. PubMed ID: 16789643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An occult pancreatic insulinoma: radio-guided surgery with 111-In-octreotide. A case report and review of the literature on pre- and intraoperative diagnosis].
    Ressetta G; Geatti O; Pozzetto B; Sustersich M; Povolato M; Ferretti G; Leggeri A
    Ann Ital Chir; 2000; 71(1):107-12; discussion 113. PubMed ID: 10829532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant insulinoma in ectopic pancreatic tissue.
    Hennings J; Garske U; Botling J; Hellman P
    Dig Surg; 2005; 22(5):377-9. PubMed ID: 16432300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome.
    Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E
    Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal.
    Davì MV; Bodei L; Ferdeghini M; Falconi M; Testoni M; Paganelli G; Oliani C; Lo Cascio V; Francia G
    Endocr Pract; 2008 Mar; 14(2):213-8. PubMed ID: 18308661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades.
    Yu J; Ping F; Zhang H; Li W; Yuan T; Fu Y; Feng K; Xia W; Xu L; Li Y
    BMC Endocr Disord; 2018 Dec; 18(1):92. PubMed ID: 30522468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
    Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
    Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide receptor radionuclide therapy with
    Magalhães D; Sampaio IL; Ferreira G; Bogalho P; Martins-Branco D; Santos R; Duarte H
    J Endocrinol Invest; 2019 Mar; 42(3):249-260. PubMed ID: 29949120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.
    Chandra P; Yarandi SS; Khazai N; Jacobs S; Umpierrez GE
    Am J Med Sci; 2010 Nov; 340(5):414-7. PubMed ID: 20724903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
    Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.
    Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A
    Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative gamma probe detection of lymph node recurrence of insulinoma.
    Pelaez N; Busquets J; Ortega M; Miralles EM; Puig J; Miret M; Munné A; Grande L
    J Surg Oncol; 2005 Sep; 91(3):209-11. PubMed ID: 16118779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-octreotide scintigraphy: a tool to select patients with endocrine pancreatic tumors for octreotide treatment?
    Keymeulen B; Bossuyt A; Peeters TL; Somers G
    Ann Nucl Med; 1995 Aug; 9(3):149-52. PubMed ID: 8534589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative gamma probe detection of insulinoma in an elderly patient with pancreatic cystic lesions.
    Rosière A; Ernst YJ; Roelants V; Vander Borght T; Michel L; Donckier JE
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):547-9. PubMed ID: 12354138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.